Eventide Asset Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Eventide Asset Management’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-27,887	Closed	-$2.37M	–	256
2025 Q1	$2.37M	Hold	27,887	–	–	0.05%	159
2024 Q4	$4.45M	Hold	27,887	–	–	0.08%	156
2024 Q3	$3.13M	Hold	27,887	–	–	0.05%	148
2024 Q2	$3.13M	Hold	27,887	–	–	0.05%	141
2024 Q1	$3.13M	Hold	27,887	–	–	0.05%	141
2023 Q4	$3.25M	Buy	+27,887	New	+$4.35M	0.05%	137
2018 Q2	–	Sell	-7	Closed	-$940K	–	151
2018 Q1	$940K	Buy	+7	New	+$851K	0.04%	134

Other funds holding YARW

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PSC

Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Eventide Asset Management's YARW Position: Q2 2025 in Review

Eventide Asset Management sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q2 2025, closing a stake of 27,887 shares — an estimated $2.37M sold.

Eventide Asset Management first reported a position in YARW in Q1 2018 and held it in 7 quarters. The position peaked at $4.45M in Q4 2024. 44 funds tracked by Wall St. Rank hold YARW as of Q2 2025.

Eventide Asset Management reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Eventide Asset Management sold 27,887 Yarrow Bioscience, Inc. Common Stock shares in Q2 2025, an estimated $2.37M.
Eventide Asset Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
Eventide Asset Management's Yarrow Bioscience, Inc. Common Stock position peaked at $4.45M in Q4 2024.
44 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q2 2025.

Based on Eventide Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.